Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia

Chiara Cavallini; Carlo Visco; Santosh Putta; Davide Rossi; Elda Mimiola; Norman Purvis; Ornella Lovato; Omar Perbellini; Erika Falisi; Monica Facco; Livio Trentin; Maria G. Romanelli; Gianpietro Semenzato; Achille Ambrosetti; Gianluca Gaidano; Giovanni Pizzolo; Alessandra Cesano; Maria T. Scupoli

doi:10.3324/haematol.2016.154450

Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia

Chiara Cavallini
, Carlo Visco
, Santosh Putta
, Davide Rossi
, Elda Mimiola
, Norman Purvis
, Ornella Lovato
, Omar Perbellini
, Erika Falisi
, Monica Facco
, Livio Trentin
, Maria G. Romanelli
, Gianpietro Semenzato
, Achille Ambrosetti
, Gianluca Gaidano
, Giovanni Pizzolo
, Alessandra Cesano
, Maria T. Scupoli

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Lettera › peer review

Lingua originale	Inglese
pagine (da-a)	e144-e147
Rivista	Haematologica
Volume	102
Numero di pubblicazione	4
DOI	https://doi.org/10.3324/haematol.2016.154450
Stato di pubblicazione	Pubblicato - 31 mar 2017

Accesso al documento

10.3324/haematol.2016.154450

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Cavallini, C., Visco, C., Putta, S., Rossi, D., Mimiola, E., Purvis, N., Lovato, O., Perbellini, O., Falisi, E., Facco, M., Trentin, L., Romanelli, M. G., Semenzato, G., Ambrosetti, A., Gaidano, G., Pizzolo, G., Cesano, A., & Scupoli, M. T. (2017). Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia. Haematologica, 102(4), e144-e147. https://doi.org/10.3324/haematol.2016.154450

@article{0157265782d74ad8b486fda9c377a4a1,

title = "Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-na{\"i}ve chronic lymphocytic leukemia",

author = "Chiara Cavallini and Carlo Visco and Santosh Putta and Davide Rossi and Elda Mimiola and Norman Purvis and Ornella Lovato and Omar Perbellini and Erika Falisi and Monica Facco and Livio Trentin and Romanelli, \{Maria G.\} and Gianpietro Semenzato and Achille Ambrosetti and Gianluca Gaidano and Giovanni Pizzolo and Alessandra Cesano and Scupoli, \{Maria T.\}",

note = "Funding Information: the authors would like to thank all patients who donated samples for this study. Grant support for this study was provided by Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona and Associazione Italiana Ricerca sul Cancro (AIRC), Milan, Italy (grant \#6599) (MGR, GS, GP, and MTS); Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona (grant \#2015.0872) (MTS); Special Program Molecular Clinical Oncology 5x1000 No. 10007 (GG); AIRC, Milan, Italy (GG); and Progetto Ricerca Finalizzata RF-2011-02349712, Ministero della Salute, Rome, Italy (GG).",

year = "2017",

month = mar,

day = "31",

doi = "10.3324/haematol.2016.154450",

language = "English",

volume = "102",

pages = "e144--e147",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "4",

}

Cavallini, C, Visco, C, Putta, S, Rossi, D, Mimiola, E, Purvis, N, Lovato, O, Perbellini, O, Falisi, E, Facco, M, Trentin, L, Romanelli, MG, Semenzato, G, Ambrosetti, A, Gaidano, G, Pizzolo, G, Cesano, A & Scupoli, MT 2017, 'Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia', Haematologica, vol. 102, n. 4, pagg. e144-e147. https://doi.org/10.3324/haematol.2016.154450

TY - JOUR

T1 - Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia

AU - Cavallini, Chiara

AU - Visco, Carlo

AU - Putta, Santosh

AU - Rossi, Davide

AU - Mimiola, Elda

AU - Purvis, Norman

AU - Lovato, Ornella

AU - Perbellini, Omar

AU - Falisi, Erika

AU - Facco, Monica

AU - Trentin, Livio

AU - Romanelli, Maria G.

AU - Semenzato, Gianpietro

AU - Ambrosetti, Achille

AU - Gaidano, Gianluca

AU - Pizzolo, Giovanni

AU - Cesano, Alessandra

AU - Scupoli, Maria T.

N1 - Funding Information: the authors would like to thank all patients who donated samples for this study. Grant support for this study was provided by Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona and Associazione Italiana Ricerca sul Cancro (AIRC), Milan, Italy (grant #6599) (MGR, GS, GP, and MTS); Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona (grant #2015.0872) (MTS); Special Program Molecular Clinical Oncology 5x1000 No. 10007 (GG); AIRC, Milan, Italy (GG); and Progetto Ricerca Finalizzata RF-2011-02349712, Ministero della Salute, Rome, Italy (GG).

PY - 2017/3/31

Y1 - 2017/3/31

UR - https://www.scopus.com/pages/publications/85016955949

U2 - 10.3324/haematol.2016.154450

DO - 10.3324/haematol.2016.154450

M3 - Letter

SN - 0390-6078

VL - 102

SP - e144-e147

JO - Haematologica

JF - Haematologica

IS - 4

ER -